Danofloxacin

Functional Class: Antimicrobial agent

Search JECFA
Click the above link to access the relevant JECFA residue monograph(s)

Search WHO
Click the above link to access the relevant WHO evaluation

Maximum residue limits for Danofloxacin

Species

Tissue

MRL

Year of Adoption

Note

Muscle

200 µg/kg

2001

None

Species

Tissue

Muscle

MRL

200 µg/kg

Year of Adoption

2001

Note

None

Liver

400 µg/kg

2001

None

Species

Tissue

Liver

MRL

400 µg/kg

Year of Adoption

2001

Note

None

Kidney

400 µg/kg

2001

None

Species

Tissue

Kidney

MRL

400 µg/kg

Year of Adoption

2001

Note

None

Fat

100 µg/kg

2001

None

Species

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

2001

Note

None

Muscle

200 µg/kg

2001

None

Species

Tissue

Muscle

MRL

200 µg/kg

Year of Adoption

2001

Note

None

Liver

400 µg/kg

2001

None

Species

Tissue

Liver

MRL

400 µg/kg

Year of Adoption

2001

Note

None

Kidney

400 µg/kg

2001

None

Species

Tissue

Kidney

MRL

400 µg/kg

Year of Adoption

2001

Note

None

Fat

100 µg/kg

2001

Fat/skin in normal proportion.

Species

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

2001

Note

Fat/skin in normal proportion.

Pig

Muscle

100 µg/kg

2001

None

Species

Pig

Tissue

Muscle

MRL

100 µg/kg

Year of Adoption

2001

Note

None

Pig

Liver

50 µg/kg

2001

None

Species

Pig

Tissue

Liver

MRL

50 µg/kg

Year of Adoption

2001

Note

None

Pig

Kidney

200 µg/kg

2001

None

Species

Pig

Tissue

Kidney

MRL

200 µg/kg

Year of Adoption

2001

Note

None

Pig

Fat

100 µg/kg

2001

None

Species

Pig

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

2001

Note

None

Showing 1 to 12 of 12 entries